Iovance Biotherapeutics, Inc.
DE ˙ DB ˙ US4622601007
3,42 € ↑0,02 (0,44%)
2026-06-02
CENA AKCJI
SecurityDE:2LB / Iovance Biotherapeutics, Inc.
InstitutionStifel Financial Corp
Latest Disclosed Ownership449,639 shares
Latest Disclosed Value $ 1,578,233
Stifel Financial Corp reports 36.33% increase in ownership of 2LB / Iovance Biotherapeutics, Inc.

On May 12, 2026 - Stifel Financial Corp filed a 13F-HR form disclosing ownership of 449,639 shares of Iovance Biotherapeutics, Inc. (DE:2LB) valued at $1,289,789 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 329,815 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of 36.33% during the quarter. The current value of the position is $1,537,765 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 449,639 119,824 36.33 1,578 75.33 0.0003
2026-02-13 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 329,815 -19,780 -5.66 900 18.73 0.0008
2025-11-12 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 349,595 123,955 54.93 759 95.36 0.0007
2025-08-14 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 225,640 60,816 36.90 388 -29.20 0.0004
2025-05-14 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 164,824 -45,175 -21.51 549 -64.74 0.0006
2025-02-13 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 209,999 -13,108 -5.88 1,554 -25.79 0.0016
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 223,107 58,787 35.78 2,095 59.00 0.0022
2024-08-13 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 164,320 -93,975 -36.38 1,318 -65.59 0.0015
2024-05-14 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 258,295 -50,459 -16.34 3,828 52.47 0.0044
2024-02-12 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 308,754 78,600 34.15 2,510 139.73 0.0032
2023-11-13 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 230,154 -96,179 -29.47 1,047 -54.42 0.0015
2023-08-14 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 326,333 177,440 119.17 2,297 152.70 0.0031
2023-05-12 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 148,893 10,968 7.95 910 3.18 0.0013
2023-02-13 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 137,925 137,925 881 0.0013
2022-02-14 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -8,735 -100.00 0 -100.00
2021-11-15 2021-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 8,735 135 1.57 215 -4.02 0.0003
2021-08-13 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 8,600 -18,702 -68.50 224 -74.07 0.0003
2021-05-14 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 27,302 -4,916 -15.26 864 -42.21 0.0014
2021-02-12 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 32,218 941 3.01 1,495 45.15 0.0027
2020-11-16 2020-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 31,277 1,050 3.47 1,030 24.10 0.0021
2020-08-14 2020-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 30,227 -2,183 -6.74 830 -14.34 0.0019
2020-05-14 2020-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 32,410 -6,970 -17.70 969 -11.10 0.0027
2020-02-13 2019-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 39,380 39,380 1,090 0.0023
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.